Article
Streamlined measurement of chimeric antigen receptor T-cell concentration, size, viability and two-color phenotyping during manufacturing.
Cytotherapy - 1 May 2024
Pajarillo Raymone, Paruzzo Luca, Carturan Alberto, Ugwuanyi Ositadimma, White Griffin, Guruprasad Puneeth, Ballard Hatcher J, Patel Ruchi P, Zhang Yunlin, Lee Yong Gu, Hong Seok Jae Albert, Dittami Gregory M, Ruella Marco
Abstract excerpt
BACKGROUND AIMS: The successful development of CD19-targeted chimeric antigen receptor (CAR) T-cell therapies has led to an exponential increase in the number of patients recieving treatment and the advancement of novel CAR T products. Therefore, there is a strong need to develop streamlined platforms that allow rapid, cost-effective, and accurate measurement of the key characteristics of CAR T cells during...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
